© Copyright 2012, vLex. All Rights Reserved.
- Language
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Antimicrobial Resistance Surveillance System
159 documents for Antimicrobial Resistance Surveillance System
-
... the extralabel use of cephalosporin antimicrobial drugs in food-producing animals. We are issuing th... fused to a sulfur-containing ring-expanded system. (Ref. 1). Certain cephalosporins are currently ap...A recent review of [beta]-lactam resistance in bacteria of animal origin states that an emergi... animal isolates has been observed in surveillance programs such as the Canadian Integrated. Program ...
-
The Food and Drug Administration (FDA, the Agency) is issuing an order prohibiting certain extralabel uses of cephalosporin antimicrobial drugs in certain food-producing animals. We are issuing this order based on evidence that certain extralabel uses of these drugs in these animals will likely cause an adverse event in humans and, therefore, present a risk to the public health.
... to the problem of cephalosporin resistance. Many of these commenters were concerned about the... fused to a sulfur-containing ring-expanded system (Ref. 1). These antimicrobials work by targeting s... human isolates has been observed in surveillance programs such as the U.S. National Antimicrobial R...
-
... in filaggrin [right arrow] NMF Antimicrobial Acidic SC pH reduces colonization by cutaneous Bar... function Immune Response Immune surveillance and antigen recognition Barrier via epidermal dend... T cell responses with T regulatory cell system (FOXP3 cells) Photoprotection Optical reflectance ... membrane, and provides plasticity and resistance to shearing forces Desquamation Proteolytic enzyme...
-
The Food and Drug Administration (FDA or the Agency) is withdrawing two 1977 notices of opportunity for a hearing (NOOH), which proposed to withdraw certain approved uses of penicillin and tetracyclines intended for use in feeds for food-producing animals based in part on microbial food safety concerns.\1\ (Refs. 1 and 2) FDA is taking this action, and closing the corresponding dockets, because: FDA is engaging in other ongoing regulatory strategies developed since the publication of the 1977 NOOHs with respect to addressing microbial food safety issues; FDA would update the NOOHs to reflect current data, information, and policies if, in the future, it decides to move forward with withdrawal of the approved uses of the new animal drugs described in the NOOHs; and FDA would need to prior...
... Questions regarding the use of antimicrobial drugs in food-. producing animals have been raised...Antimicrobial resistance is the ability of bacteria or other microbes to re... through a national public health surveillance system, known as the National Antimicrobial Resist...
-
... provision relating to the issue of antimicrobial resistance. I recognize that there's a growing co... a report concluding that our current system of producing food animals and its reliance on the ... what is happening, the traceability, surveillance programs, information internationally as well as d...
-
.... Global Surveillance and Costs: This report gives detailed recently pub... were obtained from the European Antimicrobial Resistance Surveillance System (EARSS) in Europe, ...
-
... acne and resistance mechanisms, acne and systemic infections, acne and antibiotic resistance and coa... the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermato...
-
When Klaus Stöhr left the World Health Organization to take a job at the Swiss drug giant Novartis in February, there were some who questioned whether the most prominent figure in the global fight against avian influenza had forsaken public health for profit margins. During SARS and the ongoing avian influenza situation, Stöhr also became a public figure, talking regularly to reporters and becoming one of the prime media sources of quotes about the risk of a human pandemic.
... role in establishing a global surveillance system for antimicrobial resistance in humans and ...
-
- New Report Explores New Drug Innovation and the Strategy to Combat Antibiotic Resistance Mechanisms.
.... Global Surveillance and Costs: This report gives detailed recently pub... were obtained from the European Antimicrobial Resistance Surveillance System (EARSS) in Europe, ...
-
LAKE FOREST, Ill., April 7, 2011 /PRNewswire/ -- As part of World Health Day 2011, the World Health Organization (WHO) is calling on policy makers, providers, the public and the healthcare industry to take action to combat the serious health threat of antimicrobial resistance (AMR). Aligned with these efforts, Hospira (NYSE: HSP) is focusing on the growing importance of clinical surveillance systems to help reduce AMR by helping healthcare providers optimize antibiotic therapy and provide the "right drug for the right bug. Antimicrobial agents, used to treat infections, are one of the most important advances in medicine, alleviating suffering from infectious diseases and saving countless lives over the past 70 years.(1) According to WHO, the world is at risk of losing this critical ars...
